OBJECTIVES: Classification of patients with acute respiratory distress syndrome into hyper- and hypoinflammatory subphenotypes using plasma biomarkers may facilitate more effective targeted therapy. We examined whether established subphenotypes are present not only in patients with acute respiratory distress syndrome but also in patients at risk for acute respiratory distress syndrome (ARFA) and then assessed the prognostic information of baseline subphenotyping on the evolution of host-response biomarkers and clinical outcomes. DESIGN: Prospective, observational cohort study. SETTING: Medical ICU at a tertiary academic medical center. PATIENTS: Mechanically ventilated patients with acute respiratory distress syndrome or ARFA. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We performed longitudinal measurements of 10 plasma biomarkers of host injury and inflammation. We applied unsupervised latent class analysis methods utilizing baseline clinical and biomarker variables and demonstrated that two-class models (hyper- vs hypoinflammatory subphenotypes) offered improved fit compared with one-class models in both patients with acute respiratory distress syndrome and ARFA. Baseline assignment to the hyperinflammatory subphenotype (39/104 [38%] acute respiratory distress syndrome and 30/108 [28%] ARFA patients) was associated with higher severity of illness by Sequential Organ Failure Assessment scores and incidence of acute kidney injury in patients with acute respiratory distress syndrome, as well as higher 30-day mortality and longer duration of mechanical ventilation in ARFA patients (p < 0.0001). Hyperinflammatory patients exhibited persistent elevation of biomarkers of innate immunity for up to 2 weeks postintubation. CONCLUSIONS: Our results suggest that two distinct subphenotypes are present not only in patients with established acute respiratory distress syndrome but also in patients at risk for its development. Hyperinflammatory classification at baseline is associated with higher severity of illness, worse clinical outcomes, and trajectories of persistently elevated biomarkers of host injury and inflammation during acute critical illness compared with hypoinflammatory patients. Our findings provide strong rationale for examining treatment effect modifications by subphenotypes in randomized clinical trials to inform precision therapeutic approaches in critical care.
OBJECTIVES: Classification of patients with acute respiratory distress syndrome into hyper- and hypoinflammatory subphenotypes using plasma biomarkers may facilitate more effective targeted therapy. We examined whether established subphenotypes are present not only in patients with acute respiratory distress syndrome but also in patients at risk for acute respiratory distress syndrome (ARFA) and then assessed the prognostic information of baseline subphenotyping on the evolution of host-response biomarkers and clinical outcomes. DESIGN: Prospective, observational cohort study. SETTING: Medical ICU at a tertiary academic medical center. PATIENTS: Mechanically ventilated patients with acute respiratory distress syndrome or ARFA. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We performed longitudinal measurements of 10 plasma biomarkers of host injury and inflammation. We applied unsupervised latent class analysis methods utilizing baseline clinical and biomarker variables and demonstrated that two-class models (hyper- vs hypoinflammatory subphenotypes) offered improved fit compared with one-class models in both patients with acute respiratory distress syndrome and ARFA. Baseline assignment to the hyperinflammatory subphenotype (39/104 [38%] acute respiratory distress syndrome and 30/108 [28%] ARFA patients) was associated with higher severity of illness by Sequential Organ Failure Assessment scores and incidence of acute kidney injury in patients with acute respiratory distress syndrome, as well as higher 30-day mortality and longer duration of mechanical ventilation in ARFA patients (p < 0.0001). Hyperinflammatory patients exhibited persistent elevation of biomarkers of innate immunity for up to 2 weeks postintubation. CONCLUSIONS: Our results suggest that two distinct subphenotypes are present not only in patients with established acute respiratory distress syndrome but also in patients at risk for its development. Hyperinflammatory classification at baseline is associated with higher severity of illness, worse clinical outcomes, and trajectories of persistently elevated biomarkers of host injury and inflammation during acute critical illness compared with hypoinflammatory patients. Our findings provide strong rationale for examining treatment effect modifications by subphenotypes in randomized clinical trials to inform precision therapeutic approaches in critical care.
Authors: Theodore J Iwashyna; James F Burke; Jeremy B Sussman; Hallie C Prescott; Rodney A Hayward; Derek C Angus Journal: Am J Respir Crit Care Med Date: 2015-11-01 Impact factor: 21.405
Authors: Katie R Famous; Kevin Delucchi; Lorraine B Ware; Kirsten N Kangelaris; Kathleen D Liu; B Taylor Thompson; Carolyn S Calfee Journal: Am J Respir Crit Care Med Date: 2017-02-01 Impact factor: 21.405
Authors: Carolyn S Calfee; Diana Gallagher; Jason Abbott; B Taylor Thompson; Michael A Matthay Journal: Crit Care Med Date: 2012-06 Impact factor: 7.598
Authors: David T Huang; Derek C Angus; Marc Moss; B Taylor Thompson; Niall D Ferguson; Adit Ginde; Michelle Ng Gong; Stephanie Gundel; Douglas L Hayden; R Duncan Hite; Peter C Hou; Catherine L Hough; Theodore J Iwashyna; Kathleen D Liu; Daniel S Talmor; Donald M Yealy Journal: Ann Am Thorac Soc Date: 2017-01
Authors: Eamon P Raith; Andrew A Udy; Michael Bailey; Steven McGloughlin; Christopher MacIsaac; Rinaldo Bellomo; David V Pilcher Journal: JAMA Date: 2017-01-17 Impact factor: 56.272
Authors: Carolyn S Calfee; Kevin L Delucchi; Pratik Sinha; Michael A Matthay; Jonathan Hackett; Manu Shankar-Hari; Cliona McDowell; John G Laffey; Cecilia M O'Kane; Daniel F McAuley Journal: Lancet Respir Med Date: 2018-08-02 Impact factor: 30.700
Authors: Heather S McKay; Joseph B Margolick; Otoniel Martínez-Maza; Joseph Lopez; John Phair; Giovanna Rappocciolo; Thomas N Denny; Larry I Magpantay; Lisa P Jacobson; Jay H Bream Journal: Cytokine Date: 2016-12-09 Impact factor: 3.861
Authors: Tommaso Mauri; Andrea Coppadoro; Giacomo Bellani; Michela Bombino; Nicolo' Patroniti; Giuseppe Peri; Alberto Mantovani; Antonio Pesenti Journal: Crit Care Med Date: 2008-08 Impact factor: 7.598
Authors: Yale Jiang; Brian R Rosborough; Jie Chen; Sudipta Das; Georgios D Kitsios; Bryan J McVerry; Rama K Mallampalli; Janet S Lee; Anuradha Ray; Wei Chen; Prabir Ray Journal: JCI Insight Date: 2020-07-09
Authors: Daniel Kotok; Libing Yang; John W Evankovich; William Bain; Daniel G Dunlap; Faraaz Shah; Yingze Zhang; Dimitris V Manatakis; Panayiotis V Benos; Ian J Barbash; Sarah F Rapport; Janet S Lee; Alison Morris; Bryan J McVerry; Georgios D Kitsios Journal: J Crit Care Date: 2020-01-13 Impact factor: 3.425
Authors: David M Maslove; Benjamin Tang; Manu Shankar-Hari; Patrick R Lawler; Derek C Angus; J Kenneth Baillie; Rebecca M Baron; Michael Bauer; Timothy G Buchman; Carolyn S Calfee; Claudia C Dos Santos; Evangelos J Giamarellos-Bourboulis; Anthony C Gordon; John A Kellum; Julian C Knight; Aleksandra Leligdowicz; Daniel F McAuley; Anthony S McLean; David K Menon; Nuala J Meyer; Lyle L Moldawer; Kiran Reddy; John P Reilly; James A Russell; Jonathan E Sevransky; Christopher W Seymour; Nathan I Shapiro; Mervyn Singer; Charlotte Summers; Timothy E Sweeney; B Taylor Thompson; Tom van der Poll; Balasubramanian Venkatesh; Keith R Walley; Timothy S Walsh; Lorraine B Ware; Hector R Wong; Zsolt E Zador; John C Marshall Journal: Nat Med Date: 2022-06-17 Impact factor: 87.241
Authors: Lieuwe D J Bos; Antonio Artigas; Jean-Michel Constantin; Laura A Hagens; Nanon Heijnen; John G Laffey; Nuala Meyer; Laurent Papazian; Lara Pisani; Marcus J Schultz; Manu Shankar-Hari; Marry R Smit; Charlotte Summers; Lorraine B Ware; Raffaele Scala; Carolyn S Calfee Journal: Eur Respir Rev Date: 2021-02-02
Authors: Vineet K Raghu; Christopher M Horvat; Patrick M Kochanek; Ericka L Fink; Robert S B Clark; Panayiotis V Benos; Alicia K Au Journal: Pediatr Crit Care Med Date: 2021-10-01 Impact factor: 3.971
Authors: Raul Dos Reis Ururahy; César Albuquerque Gallo; Bruno Adler Maccagnan Pinheiro Besen; Marcelo Ticianelli de Carvalho; José Mauro Ribeiro; Rogério Zigaib; Pedro Vitale Mendes; Marcelo Park Journal: Rev Bras Ter Intensiva Date: 2021 Apr-Jun